Peter Goff, MD PhD

Peter Goff, MD PhD

University of Washington

H-index: 17

North America-United States

About Peter Goff, MD PhD

Peter Goff, MD PhD, With an exceptional h-index of 17 and a recent h-index of 15 (since 2020), a distinguished researcher at University of Washington, specializes in the field of Radiation Oncology, Virology, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma

Postoperative Radiation Therapy Is Indicated for “Low-Risk” Pathologic Stage I Merkel Cell Carcinoma of the Head and Neck Region but Not for Other Locations

Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma

Preclinical Ultra-High Dose Rate (FLASH) Proton Radiation Therapy System for Small Animal Studies

A Novel Approach to Support Quality Assurance (QA) of Intensity Modulated Neutron Therapy (IMNT)

LB1690 Definitive radiotherapy for initial management of merkel cell carcinoma: Assessing a novel hypo-fractionated regimen

Radiation therapy for low‐and high‐risk perineural invasion in head and neck cutaneous squamous cell carcinoma: Clinical outcomes and patterns of failure

610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal …

Peter Goff, MD PhD Information

University

Position

Resident Physician Radiation Oncology at

Citations(all)

1749

Citations(since 2020)

774

Cited By

1316

hIndex(all)

17

hIndex(since 2020)

15

i10Index(all)

23

i10Index(since 2020)

21

Email

University Profile Page

Google Scholar

Peter Goff, MD PhD Skills & Research Interests

Radiation Oncology

Virology

Immunotherapy

Top articles of Peter Goff, MD PhD

Title

Journal

Author(s)

Publication Date

Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma

Journal of the American Academy of Dermatology

Nora A Alexander

Stephanie K Schaub

Peter H Goff

Daniel S Hippe

Song Y Park

...

2024/2/1

Postoperative Radiation Therapy Is Indicated for “Low-Risk” Pathologic Stage I Merkel Cell Carcinoma of the Head and Neck Region but Not for Other Locations

Advances in Radiation Oncology

Marika M Bierma

Peter H Goff

Daniel S Hippe

Kristina Lachance

Stephanie K Schaub

...

2024/2/1

Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma

JAMA dermatology

Mark B Faries

2024/5/15

Preclinical Ultra-High Dose Rate (FLASH) Proton Radiation Therapy System for Small Animal Studies

Advances in Radiation Oncology

Ning Cao

Danielle P Johnson Erickson

Eric C Ford

Robert C Emery

Marissa Kranz

...

2024/3/1

A Novel Approach to Support Quality Assurance (QA) of Intensity Modulated Neutron Therapy (IMNT)

International Journal of Radiation Oncology, Biology, Physics

GA Sandison

A Lehnert

RS Miyaoka

M Kranz

M Kim

...

2023/10/1

LB1690 Definitive radiotherapy for initial management of merkel cell carcinoma: Assessing a novel hypo-fractionated regimen

Journal of Investigative Dermatology

A Menon

ET Huynh

PH Goff

K Lachance

MH Nguyen

...

2023/9/1

Radiation therapy for low‐and high‐risk perineural invasion in head and neck cutaneous squamous cell carcinoma: Clinical outcomes and patterns of failure

Head & Neck

Theodore A Gobillot

Matthew Greer

Upendra Parvathaneni

Jay J Liao

George E Laramore

...

2023/9

610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal …

Peter H Goff

Kelsey K Baker

Sylvia M Lee

Scott S Tykodi

Shailender Bhatia

...

2023/11/1

The evolving treatment landscape of Merkel cell carcinoma

Neha Singh

Erin M McClure

Tomoko Akaike

Song Y Park

Emily T Huynh

...

2023/9

Efficacy of Single-Fraction Postoperative Radiotherapy in Resected, Early-Stage Merkel Cell Carcinoma with High-Risk Features

International Journal of Radiation Oncology, Biology, Physics

PH Goff

ET Huynh

K Lachance

N Harikrishnan

M Cook

...

2023/10/1

512 Single-fraction postoperative radiotherapy in early-stage merkel cell carcinoma (MCC): Effectiveness and reduced toxicity

Journal of Investigative Dermatology

ET Huynh

PH Goff

K Lachance

N Harikrishnan

T Akaike

...

2023/5/1

Adaptation of a Clinical Proton Pencil Beam Scanning System for FLASH Experiments

International Journal of Radiation Oncology, Biology, Physics

DPJ Erickson

J Saini

N Cao

EC Ford

R Emery

...

2023/10/1

Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Recurrent/Metastatic Squamous Cell Carcinomas of the Head and Neck Previously Treated with Immune Checkpoint …

International Journal of Radiation Oncology, Biology, Physics

CP Rodriguez

J Fromm

JJ Liao

GE Laramore

SS Lo

...

2022/11/1

Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy

Journal of Investigative Dermatology

Rashmi Bhakuni

Peter H Goff

Jung Hyun Lee

Thomas Pulliam

Shira Tabachnick-Cherny

...

2022/10/1

848 Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapy

Journal of Investigative Dermatology

R Bhakuni

P Goff

JH Lee

T Pulliam

S Tabachnick-Cherny

...

2022/8/1

Neoadjuvant therapy induces a potent immune response to sarcoma, dominated by myeloid and B cells

Clinical Cancer Research

Peter H Goff

Laura Riolobos

Bonnie J LaFleur

Matthew B Spraker

Y David Seo

...

2022/4/14

Single Fraction Radiotherapy as Postoperative Treatment (SF-PORT) for Resected, Stage I/II Merkel Cell Carcinoma

International Journal of Radiation Oncology, Biology, Physics

PH Goff

SK Schaub

Kristina Lachance

ET Huynh

Nikhil Harikrishnan

...

2021/11/1

In Regard to Barker

Advances in Radiation Oncology

Peter H Goff

Stephanie K Schaub

Maclean M Cook

Paul N Nghiem

Upendra Parvathaneni

2021/5/1

LB820 ATR inhibition for potentiation of immunogenicity and cell death in Merkel Cell Carcinoma refractory to PD-1 pathway blockade

Journal of Investigative Dermatology

R Bhakuni

P Goff

J Lee

T Pulliam

S Cherny

...

2021/9/1

Radiation and Modulation of the Tumor Immune Microenvironment in Non–Small Cell Lung Cancer

Peter H Goff

Jing Zeng

Ramesh Rengan

Stephanie K Schaub

2021/4/1

See List of Professors in Peter Goff, MD PhD University(University of Washington)